Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2000
10/17/2000US6133420 GPR14 polypeptides
10/17/2000US6133419 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
10/17/2000US6133418 Synthetic peptide inhibitors of HIV transmission
10/17/2000US6133324 Use of perillyl alcohol in organ transplantation
10/17/2000US6133304 Treating fibrosis, ventricular dilation, and/or heart failure in a mammal by administering an antifibrotic amount of a mixture of an angiotensin-converting enzyme(ace) inhibitor and at least one matrix metalloproteinase(mmp) inhibitor
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133256 Selective factor Xa inhibitors
10/17/2000US6133250 Oral 1α-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D
10/17/2000US6133246 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
10/17/2000US6133243 Administering to tumor a complex consisting of liposomal viral dna, said viral dna being purified adenoviral dna not in an expression vector and lacking expressed viral oncoprotein that binds to functional p53 tumor suppressor protein
10/17/2000US6133236 Protein named kalinin has been found to provide adhesion between the human dermis and epidermis
10/17/2000US6133235 Glucagon-like insulinotropic peptides compositions and methods
10/17/2000US6133234 Administering an effective amount of hepatocyte growth factor
10/17/2000US6133233 Administering into mammal's bloodstream reperfusion injury-reducing amount of specified peptide
10/17/2000US6133232 Protein or fragment having neurotrophic, growth or differentiation factor activity in xenopus embryos
10/17/2000US6133231 Angiogenesis using hepatocyte growth factor
10/17/2000US6133230 Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and TGF-β, optionally in combination with IGF-1
10/17/2000US6133032 Antisense modulation of PI3 kinase p110 beta expression
10/17/2000US6133031 Antisense inhibition of focal adhesion kinase expression
10/17/2000US6133029 Replication defective viral vectors for infecting human cells
10/17/2000US6133028 For gene therapy
10/17/2000US6133024 Recombinant vector which codes for an rna capable of forming a triple helix with target nucleic acid; for transcription of the rna in target cells
10/17/2000US6133013 Nucleotide sequence coding protein with clot dissolving activity; for treatment blood coagulation defects
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6133010 Chlamysin B antibacterial protein, a protein gene for and an expression system for same
10/17/2000US6133007 Phosphodiesterase 8A
10/17/2000US6133006 Nucleotide sequence coding an enzmatic polypeptide associated with signal transduction; for the diagnosis and treatment of osteoporosis, inflammation, skin disorders, asthma, nervous system disorders, cancer, eating disorders and infections
10/17/2000US6133005 Enzymatic protein; for the treatment of nervous system disorders associated with thamine vitamin deficiency
10/17/2000US6132992 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132990 Recombinant methods for production of serine protease inhibitors and DNA sequences useful for same
10/17/2000US6132987 Polypeptide associated with macrophages; for diagnosis and treatment of inflammation, arthritis and atherosclerosis
10/17/2000US6132980 Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes
10/17/2000US6132973 Nucleotide sequence coding protein associated with gene expression; for the diagnosis, prevention, and treatment of defects associated with cell proliferation
10/17/2000US6132970 Rearranging nucleotide sequences; extending chains of nucleotide sequence with regions of both homogeneity and heterogeneity in multiple cycles, screening rearranged nucleotide sequences to detect desired properties
10/17/2000US6132967 Ribozyme treatment of diseases or conditions related to levels of intercellular adhesion molecule-1 (ICAM-1)
10/17/2000US6132966 Enzymatic nucleic acid which specifically prevents viral replication; for the treatment of transformed hepatocytes and suppression of viral infection humans, animals and primates
10/17/2000US6132962 Plasmid coding ribozyme; for the prevention of viral infection
10/17/2000US6132775 Treating gram-negative bacterial infections in mammals by administering purified, isolated polypeptide having bactericidal/permeability-increasing protein activity
10/17/2000US6132774 Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone
10/17/2000US6132759 Medicaments containing gelatin cross-linked with oxidized polysaccharides
10/17/2000US6132734 Cloning of mite allergens
10/17/2000US6132730 Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment
10/17/2000US6132729 Coagulation-deficient tissue factor for use in effecting specific coagulation and for use in tumor treatment
10/17/2000US6132728 Hedgehog-derived polypeptides
10/17/2000US6132727 Enzyme-activated botanical food supplement composition
10/17/2000US6132722 Recombinant antibody-enzyme fusion proteins
10/17/2000US6132721 Non-Toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same
10/17/2000US6132718 Using a vaccine comprising antibodies and anti-idiotype antibodies that mimic an epitope of antigen that is associated with a tumor or infectious agent.
10/17/2000US6132717 Administering to said mammals an endoproteolytically active amount of furin produced by a eukaryotic host cell.
10/17/2000US6132715 Method of inhibiting biosynthesis of tumor necrosis factor
10/17/2000US6132713 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
10/17/2000US6132712 Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
10/17/2000US6132697 Radiopharmaceutical compositions capable of localizing at sites of thrombus
10/17/2000US6132420 Osmotic delivery system and method for enhancing start-up and performance of osmotic delivery systems
10/17/2000US6131578 Inhibitors of UDP-G1cNAc:Ga1β1-3Ga1NAcαR β1-6 N-acetylglucosaminyltransferase (core 2 G1cNAc-T) and use of the inhibitors to prevent or treat cardiomyopathy associated with diabetes
10/17/2000US6131567 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
10/17/2000CA2196308C Peptide, bronchodilator and blood flow ameliorant
10/17/2000CA2192944C Stimulation of hair growth by peptide-copper complexes
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/17/2000CA2177357C Pna-dna-pna chimeric macromolecules
10/17/2000CA2104899C Antibodies to plasmodium falciparum
10/17/2000CA1341123C Filamentous hemagglutinin of b. pertussis
10/17/2000CA1341118C Nucleic acid and methods for the synthesis of novel decay accelerating factor compositions
10/12/2000WO2000060359A2 Interactions of ku polypeptides
10/12/2000WO2000060357A1 Tandem immuno-assay for cancer
10/12/2000WO2000060122A1 IDENTIFICATION OF A cDNA ASSOCIATED WITH ISCHEMIA IN HUMAN HEART TISSUE
10/12/2000WO2000060117A2 Prediction of risk of interstitial lung disease
10/12/2000WO2000060109A1 Amplification of cyp24 and uses thereof
10/12/2000WO2000060100A1 Dsp-9 dual-specificity map kinase phosphatase
10/12/2000WO2000060099A1 Dsp-4 dual-specificity map kinase phosphatase
10/12/2000WO2000060094A1 Modified lactococci expressing a catalase and their uses
10/12/2000WO2000060090A1 Compounds and methods for the diagnosis and treatment of b. microti infection
10/12/2000WO2000060085A1 Fibroblast growth factor-20
10/12/2000WO2000060083A1 Novel protein associated with cell stress response
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000060078A2 Latheo encodes a subunit of the origin of recognition complex
10/12/2000WO2000060077A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
10/12/2000WO2000060076A2 Compositions for the treatment and diagnosis of breast cancer and methods for their use
10/12/2000WO2000060071A1 Microtubule-associated protein tpx2
10/12/2000WO2000060068A1 Gene expression base sequences for therapeutic use and drugs for gene therapy
10/12/2000WO2000060066A1 Protein-protein from s. cerevisiae and methods of using same
10/12/2000WO2000060057A1 Rat gpr10
10/12/2000WO2000060056A1 Mouse edg5 gene
10/12/2000WO2000060051A2 Arpe-19 as a platform cell line for encapsulated cell-based delivery
10/12/2000WO2000060050A2 Recombinant influenza viruses for vaccines and gene therapy
10/12/2000WO2000059944A1 A monoclonal antibody against estrogen stimulated leucine aminopeptidase
10/12/2000WO2000059942A2 Human obesity protein binding protrein-2 homolog and uses thereof
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059940A2 Platelet-derived growth factor related gene and protein
10/12/2000WO2000059939A1 COMPOUNDS AND METHODS FOR STIMULATING β-CATENIN MEDIATED GENE EXPRESSION AND DIFFERENTIATION
10/12/2000WO2000059938A1 Angiopoietin-like proteins, crisp proteins and polynucleotides encoding same
10/12/2000WO2000059937A1 Silver-containing complex protein and antibacterial/antifungal agents and antibacterial/antifungal papers with the use of the same
10/12/2000WO2000059935A1 Anti-apoptotic fusion polypeptide
10/12/2000WO2000059932A1 Influenza virus hemagglutinin-binding peptides
10/12/2000WO2000059931A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use
10/12/2000WO2000059930A1 A method of treating cancer
10/12/2000WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus
10/12/2000WO2000059928A1 Chemokine-derived synthetic peptides
1 ... 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 2347 2348 2349 2350 2351 2352 2353 2354 2355 2356 ... 3163